BRPI0917026A2 - uso de sucralose como agente granulador - Google Patents

uso de sucralose como agente granulador

Info

Publication number
BRPI0917026A2
BRPI0917026A2 BRPI0917026A BRPI0917026A BRPI0917026A2 BR PI0917026 A2 BRPI0917026 A2 BR PI0917026A2 BR PI0917026 A BRPI0917026 A BR PI0917026A BR PI0917026 A BRPI0917026 A BR PI0917026A BR PI0917026 A2 BRPI0917026 A2 BR PI0917026A2
Authority
BR
Brazil
Prior art keywords
sucralose
granulating agent
granulating
agent
Prior art date
Application number
BRPI0917026A
Other languages
English (en)
Inventor
Christopher E Szymczak
Kristin Costello
Ryan Snyder
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0917026A2 publication Critical patent/BRPI0917026A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0917026A 2008-08-08 2009-08-07 uso de sucralose como agente granulador BRPI0917026A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8731108P 2008-08-08 2008-08-08
PCT/US2009/053077 WO2010017433A2 (en) 2008-08-08 2009-08-07 Use of sucralose as a granulating agent

Publications (1)

Publication Number Publication Date
BRPI0917026A2 true BRPI0917026A2 (pt) 2016-02-16

Family

ID=41653160

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917026A BRPI0917026A2 (pt) 2008-08-08 2009-08-07 uso de sucralose como agente granulador

Country Status (8)

Country Link
US (1) US20100034894A1 (pt)
EP (1) EP2328558A2 (pt)
CN (1) CN102112114A (pt)
AU (1) AU2009279521A1 (pt)
BR (1) BRPI0917026A2 (pt)
CA (1) CA2732105A1 (pt)
MX (1) MX2011001487A (pt)
WO (1) WO2010017433A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278913A1 (en) * 2009-04-30 2010-11-04 Sancilio & Company Chewable tablet
CN106421797A (zh) 2009-10-01 2017-02-22 艾戴尔医药公司 口服给予的皮质类固醇组合物
US10687547B2 (en) 2012-02-15 2020-06-23 Kraft Foods Group Brands Llc Compositions and methods for inhibiting precipitation of dyes in a beverage
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
CN103239412A (zh) * 2013-05-15 2013-08-14 北京科源创欣科技有限公司 一种含洛哌丁胺或其盐酸盐的药物组合物及其制备方法
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
HUE042009T2 (hu) 2013-12-23 2019-06-28 Dr Falk Pharma Gmbh Optimalizált gyógyszerkiszerelés a nyelõcsõ gyulladásos elváltozásainak kezelésére
AU2016246583B2 (en) * 2015-04-07 2020-06-25 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN106521561B (zh) * 2016-11-01 2019-05-28 攀钢集团钛业有限责任公司 镁电解槽流水线及熔镁锭的方法
JP6639034B2 (ja) * 2018-06-13 2020-02-05 大原薬品工業株式会社 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠
CN111450068A (zh) * 2019-01-21 2020-07-28 江苏先声药业有限公司 一种碳酸司维拉姆药物组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5136031A (en) * 1990-07-09 1992-08-04 Tate & Lyle Public Limited Company Chlorination of sugars
ES2196079T3 (es) * 1994-09-22 2003-12-16 Akzo Nobel Nv Procedimiento de fabricacion de unidades posologicas por medio de una granulacion por via humeda.
US5498709A (en) * 1994-10-17 1996-03-12 Mcneil-Ppc, Inc. Production of sucralose without intermediate isolation of crystalline sucralose-6-ester
DE19617487A1 (de) * 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
JP3735426B2 (ja) * 1996-12-11 2006-01-18 株式会社東芝 不揮発性半導体記憶装置及びその製造方法
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
US20020122823A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Soft tablet containing dextrose monohydrate
EP2332523B8 (en) * 2001-10-12 2022-04-20 Aquestive Therapeutics, Inc. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
WO2005007105A2 (en) * 2003-07-10 2005-01-27 Smithkline Beecham Corporation Pharmaceutical compositions
US8062659B2 (en) * 2004-02-20 2011-11-22 Novartis Ag Dietary fiber composition
DE602006014958D1 (de) * 2005-04-26 2010-07-29 Dainippon Sumitomo Pharma Co Granulatzubereitung mit biguanidverbindung
US20080031947A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. Orally dissolvable/disintegrable lyophilized dosage forms containing protected
CL2008003827A1 (es) * 2007-12-21 2009-07-24 Aptalis Pharmatech Inc Composicion para tabletas de desintegracion oral que comprende al menos una droga ( temazepam), 0,5-3% de un polimero aglutinanete para odt, un alcohol de azucar y/o sacarido, y un desintegrante; metodo para prepararla; util para tratar una enfermedad o condicion como un trastorno del sueño en pacientes con disfagia..

Also Published As

Publication number Publication date
US20100034894A1 (en) 2010-02-11
AU2009279521A1 (en) 2010-02-11
WO2010017433A3 (en) 2010-06-24
CA2732105A1 (en) 2010-02-11
MX2011001487A (es) 2011-03-30
WO2010017433A2 (en) 2010-02-11
EP2328558A2 (en) 2011-06-08
CN102112114A (zh) 2011-06-29

Similar Documents

Publication Publication Date Title
BRPI0917026A2 (pt) uso de sucralose como agente granulador
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BRPI0719210A2 (pt) Uso de compostos espiro-oxindol como agentes terapêuticos
DK3372238T3 (da) Insulinformuleringer til hurtig optagelse
BRPI0914895A2 (pt) artigo absorvente
BRPI0918372A2 (pt) artigo absorvente
BRPI0820241A2 (pt) artigo absorvente
BRPI0821175A2 (pt) artigo absorvente
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BR112012005247A2 (pt) agente antifitoviral
DE112009000964A5 (de) Tampon
BRPI1013985A2 (pt) Agentes de proteção
BRPI1009465A2 (pt) Formulação
DK2237727T3 (da) Vævsretraktor
DE112008003934A5 (de) Kosmetikmaske
BRPI0822612A2 (pt) artigo absorvente
BRPI0909223A2 (pt) uso de catepsaina c
BRPI1013650A2 (pt) neutralização através de agente de volume
BRPI0909840A2 (pt) Uso de 4-tio-2-deoxinucleosídios
BRPI0905779A2 (pt) artigo absorvente
BRPI1006474A2 (pt) "gatilho"
BRPI0923835A2 (pt) Agente de formação de espuma
BRPI0822637A2 (pt) Uso de lanosta-8, 24-dien-3-óis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]